SPARC Activators

Common SPARC Activators include, but are not limited to L-Ascorbic acid, cell culture CAS 50-81-7, β-Estradiol CAS 50-28-2, Tamoxifen CAS 10540-29-1, Resveratrol CAS 501-36-0 and Forskolin CAS 66575-29-9.

SPARC, which stands for Secreted Protein, Acidic and Rich in Cysteine, activators are substances that enhance the activity or expression of SPARC, also known as osteonectin or BM-40. SPARC is a glycoprotein that belongs to the matricellular protein family. It is secreted into the extracellular matrix (ECM) by various cell types, including fibroblasts, osteoblasts, and endothelial cells. SPARC is involved in a wide range of physiological and pathological processes, particularly in the context of tissue remodeling, wound healing, and the modulation of cell-matrix interactions. This protein is highly conserved across species, highlighting its importance in biological systems.

SPARC plays a multifaceted role in the ECM. It interacts with different ECM components, including collagens, fibronectin, and calcium-binding proteins, influencing their assembly and stability. Additionally, SPARC can modulate cell behavior by affecting cell adhesion, migration, and proliferation. It also participates in tissue development, angiogenesis, and inflammation. The expression of SPARC can be regulated by various signaling pathways, growth factors, and cytokines. Consequently, substances that activate SPARC may have a significant impact on tissue homeostasis and repair processes. Understanding the mechanisms of SPARC activation and its downstream effects is essential for unraveling its complex role in tissue biology and pathology. Researchers studying SPARC activators aim to elucidate how these molecules influence ECM dynamics, cell behavior, and tissue responses in different contexts, from normal development to disease states.